NYSE:RCUSBiotechs
Assessing Arcus Biosciences (RCUS) Valuation After Recent Share Price Rebound And Casdatifan Expectations
Arcus Biosciences stock: event driven overview
Arcus Biosciences (RCUS) has caught investor attention after recent trading action, with the stock now sitting around $20.37. That move comes against a mixed return profile across the past month and past 3 months.
See our latest analysis for Arcus Biosciences.
The latest move puts Arcus Biosciences at US$20.37, with the 1 day share price return of 4.25% and 7 day share price return of 7.27% sitting against a weaker 90 day share price return of a...